Skip to Main Content

Advertisement

Skip Nav Destination

OnlineFirst

Clinical Trials: Targeted Therapy June 21 2024
A Proof-of-Concept Study of Sequential Treatment with the HDAC Inhibitor Vorinostat following BRAF and MEK Inhibitors in BRAFV600-Mutated Melanoma
Clin Cancer Res (2024)
Translational Cancer Mechanisms and Therapy June 21 2024
Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth
Clin Cancer Res (2024)
Clinical Trials: Immunotherapy June 21 2024
Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial
Clin Cancer Res (2024)
Research Article June 20 2024
Identification of therapy-induced clonal evolution and resistance pathways in minimal residual clones in multiple myeloma through single-cell sequencing
Clin Cancer Res (2024)
Research Article June 20 2024
Ibrutinib and R-GemOx in patients with relapsed or refractory diffuse large B-cell lymphoma of non-GCB type: Phase II clinical trial of the Spanish GELTAMO group
Clin Cancer Res (2024)
CCR Drug Updates June 20 2024
FDA Approval Summary: Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer
Clin Cancer Res (2024)
Review June 20 2024
Arming Vδ2 T Cells with Chimeric Antigen Receptors to Combat Cancer
Clin Cancer Res (2024)
Review June 18 2024
From Rarity to Reality: Osimertinib’s Promising Horizon in Treating Uncommon EGFR Mutations in Non–Small Cell Lung Cancer
Clin Cancer Res (2024)
Translational Cancer Mechanisms and Therapy June 18 2024
MYC Inhibition Potentiates CD8+ T Cells Against Multiple Myeloma and Overcomes Immunomodulatory Drug Resistance
Clin Cancer Res (2024)
Precision Medicine and Imaging June 18 2024
Clinical and Genomic Landscape of RAS Mutations in Gynecologic Cancers
Clin Cancer Res (2024)
Perspective June 17 2024
An evaluation of novel oncology approvals with a PMR/C for assessing data in racial and ethnic populations underrepresented in premarket clinical trials
Clin Cancer Res (2024)
CCR Drug Updates June 14 2024
FDA Approval Summary: Repotrectinib for locally advanced or metastatic ROS1-positive non-small cell lung cancer
Clin Cancer Res (2024)
Research Article June 14 2024
Nivolumab With or Without Ipilimumab Combined with Stereotactic Body Radiotherapy in patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 Study
Clin Cancer Res (2024)
Perspective June 14 2024
Bridging the Gap from Bench to Bedside: A Call for In Vivo Preclinical Models to Advance Endometrial Cancer and Cervical Cancer Immuno-oncology Research
Clin Cancer Res (2024)
Precision Medicine and Imaging June 14 2024
Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment
Clin Cancer Res (2024)
Translational Cancer Mechanisms and Therapy June 14 2024
Bystander Effects, Pharmacokinetics, and Linker-Payload Stability of EGFR-Targeting Antibody-Drug Conjugates Losatuxizumab Vedotin and Depatux-M in Glioblastoma Models
Clin Cancer Res (2024)
Research Briefs: Clinical Trial Brief Reports June 13 2024
Phase II Clinical Trial of Intravenous Levothyroxine to Mitigate Pharyngocutaneous Fistula in Euthyroid Patients Undergoing Salvage Laryngectomy
Clin Cancer Res (2024)
Translational Cancer Mechanisms and Therapy June 13 2024
Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving ALK-Targeted Therapy
Clin Cancer Res (2024)
Clinical Trials: Targeted Therapy June 13 2024
Antibody–Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer
Clin Cancer Res (2024)
Translational Cancer Mechanisms and Therapy June 13 2024
CDKN2A/B Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition
Clin Cancer Res (2024)
Research Article June 13 2024
A five-year follow-up clinical study of the B cell maturation antigen chimeric antigen receptor-T cell therapy HDS269B in patients with relapsed or refractory multiple myeloma
Clin Cancer Res (2024)
Perspective June 13 2024
Biological sample collection to advance research and treatment: a Fight Osteosarcoma Through European Research (FOSTER) and Euro Ewing Consortium (EEC) statement.
Clin Cancer Res (2024)
Research Article June 13 2024
A phase II study of potentiation of pembrolizumab with binimetinib and bevacizumab in refractory microsatellite stable colorectal cancer
Clin Cancer Res (2024)
CCR Translations June 13 2024
Double-stranded RNA to mimic viral infection for cancer immunotherapy
Clin Cancer Res (2024)
CCR Translations June 13 2024
GD2 target antigen and CAR T cells: does it take more than 2 to tango?
Clin Cancer Res (2024)
Research Article June 12 2024
A Novel Approach to Quantify Heterogeneity of Intrahepatic Cholangiocarcinoma: the Hidden-Genome Classifier
Clin Cancer Res (2024)
Research Article June 12 2024
Tissue-free liquid biopsies combining genomic and methylation signals for minimal residual disease detection in patients with early colorectal cancer from the UK TRACC Part B study
Clin Cancer Res (2024)
Research Article June 12 2024
Targeting GPC2 on intraocular and CNS metastatic retinoblastomas with local and systemic delivery of CAR T-cells
Clin Cancer Res (2024)
Research Article June 12 2024
A PDE3A-SLFN12 Molecular Glue Exhibits Significant Antitumor Activity in TKI-Resistant Gastrointestinal Stromal Tumors
Clin Cancer Res (2024)
Translational Cancer Mechanisms and Therapy June 12 2024
Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
Clin Cancer Res (2024)
Translational Cancer Mechanisms and Therapy June 12 2024
Cervicovaginal Metabolome and Tumor Characteristics for Endometrial Cancer Detection and Risk Stratification
Clin Cancer Res (2024)
Clinical Trials: Immunotherapy June 12 2024
Phase II Study to Determine the Antitumor Activity and Safety of Simlukafusp Alfa (FAP-IL2v) Combined with Atezolizumab in Esophageal Cancer
Clin Cancer Res (2024)
CCR Translations June 12 2024
CHIPing Away at Proteomics to Find Correlations with Myeloid Neoplasms
Clin Cancer Res (2024)
CCR Translations June 11 2024
Optimizing ATR inhibition and cisplatin synergy in Ewing sarcoma
Clin Cancer Res (2024)
Review June 11 2024
Clinical updates and surveillance recommendations for DNA replication-repair deficiency syndromes in children and young adults
Clin Cancer Res (2024)
Perspective June 11 2024
Neuroblastoma Predisposition and Surveillance—An Update from the 2023 AACR Childhood Cancer Predisposition Workshop
Clin Cancer Res (2024)
Translational Cancer Mechanisms and Therapy June 11 2024
T-Cell Characteristics Impact Response and Resistance to T-Cell–Redirecting Bispecific Antibodies in Multiple Myeloma
Clin Cancer Res (2024)
Translational Cancer Mechanisms and Therapy June 11 2024
A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1
Clin Cancer Res (2024)
Research Article June 11 2024
Incorporating Supramaximal Resection into Survival Stratification of IDH-Wildtype Glioblastoma: A Refined Multi-institutional Recursive Partitioning Analysis
Clin Cancer Res (2024)
Special Report June 10 2024
Reflections and Roadmaps: Career Development Beyond the FDA-AACR Oncology Educational Fellowship
Clin Cancer Res (2024)
CCR Drug Updates June 10 2024
FDA Approval Summary: Durvalumab and Pembrolizumab, Immune Checkpoint inhibitors for the Treatment of Biliary Tract Cancer
Clin Cancer Res (2024)
Research Article June 7 2024
Missense mutations in Myc Box I influence nucleocytoplasmic transport to promote leukemogenesis.
Clin Cancer Res (2024)
Research Article June 7 2024
A Histopathologic Correlation Study Evaluating Glymphatic Function in Brain Tumors by Multi-Parametric MRI
Clin Cancer Res (2024)
Research Article June 7 2024
Inhibition of aberrantly overexpressed Polo-like kinase 4 is a potential effective treatment for DNA damage repair-deficient uterine leiomyosarcoma
Clin Cancer Res (2024)
Translational Cancer Mechanisms and Therapy June 7 2024
Anti–4-1BB×PDL1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD1 Blockade
Clin Cancer Res (2024)
Clinical Trials: Immunotherapy June 7 2024
Toripalimab Plus Bevacizumab as First-line Treatment for Advanced Hepatocellular Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Trial
Clin Cancer Res (2024)
Precision Medicine and Imaging June 7 2024
Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant Chemotherapy
Clin Cancer Res (2024)
Research Briefs: Clinical Trial Brief Reports June 6 2024
Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity from a Phase I Study of Simlukafusp Alfa (FAP-IL2v) in Advanced/Metastatic Solid Tumors
Clin Cancer Res (2024)
CCR Translations June 6 2024
There Is More to Length of Survival Than Survival: Endpoints in Oncology Trials
Clin Cancer Res (2024)
Translational Cancer Mechanisms and Therapy June 6 2024
Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma
Clin Cancer Res (2024)
Page 1 of 3
Close Modal

or Create an Account

Close Modal
Close Modal